Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended June 30, 2022
Filing Date: September 22, 2022
This filing incorporates by reference the Unaudited Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the six-month period ended June 30, 2022. The primary financial data and operational details are contained in Exhibits 99.1 and 99.2, which are not included in the provided text.
Key Financial Metrics
The provided text serves as a cover page and index for the financial statements. It does not contain specific numerical values for the following metrics:
- Revenue
- Net Profit/Loss
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any specific financial metric; these figures are located in the attached exhibits referenced in the document.
Material Changes
The text does not disclose specific material changes in financial performance or operations compared to the prior comparable period. Such analysis is contained within the MD&A (Exhibit 99.2) referenced in this filing.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are expected to be found in the attached Management's Discussion and Analysis (Exhibit 99.2).
Investor Verification Checklist
- Review Exhibit 99.1 for the actual Unaudited Interim Condensed Consolidated Financial Statements to verify revenue, cash burn, and balance sheet strength.
- Review Exhibit 99.2 for the MD&A to understand the reasons behind financial results and any operational updates.
- Confirm the company's cash runway and liquidity position given the lack of revenue data in the cover text.
- Verify the status of the Registration Statements on Form F-3 and Form S-8 into which this report is incorporated.